You are using an older browser version. Please use a supported version for the best MSN experience.

AbbVie is buying Botox producer Allergan for about $63 billion

AbbVie is buying Allergan for $188.24 per share, at a premium of almost 45 percent. Wall Street Journal reporter who broke the story, Jonathan Rockoff, calls into the "Squawk Box" to discuss the story.

Recent Videos

Featured Partners

image beaconimage beaconimage beacon